Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries With DiabetesRosen AB, Hamel MB, Weinstein MC, et al (Univ of Michigan, Ann Arbor; Harvard School of Public Health, Boston; Harvard Univ, Cambridge, Mass) Ann Intern Med 143:89-99, 2005§